LOS ANGELES — Neutralizing antibodies against mpox generated by the Jynneos vaccine were short lived — lasting less than a year — if patients had never received a smallpox vaccine as children, researchers said.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.